Catalyst Wire Dossier Catalyst Wire Dossier

BIBR 953 ZW IV

· Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BIBR 953 ZW IV, covering 2014-06-23 to 2014-06-23. Get the full timeline:

Most recent: Clinical Trial Update: Tolerability of BIBR 953 ZW IV and Bioavailability of BIBR 1048 Tablet and Solution in Healthy Males [Phase 1]

See pricing